Regenity Biosciences (Formerly Polyganics)

Regenity Biosciences is a global leader in regenerative medicine, focusing on the development and manufacturing of bioresorbable technologies for tissue and bone repair. Founded in 1997 by Dr. Shu-Tung Li, the company operates from its headquarters in Paramus, New Jersey, and additional facilities in Oakland and Allendale, New Jersey, as well as Groningen, the Netherlands. With over 275 employees, Regenity delivers more than four million devices annually to medical technology clients in 86 countries. The company's product portfolio includes a variety of collagen-based and synthetic polymer bioresorbable implants designed for multiple medical fields, such as dental, spine, orthopedics, sports medicine, advanced wound care, neurosurgery, and nerve repair. Regenity partners with original equipment manufacturers (OEMs) to provide these innovative solutions, emphasizing scientific rigor and ethical transparency in its operations. The company is committed to fostering a diverse and inclusive culture, focusing on collaboration and collective success.

• Employees 44
• Founded 1997
• Total Funding $2728936